MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer's Disease and Dementia 14 July
MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders 17 June
